维普中文期刊产品整合服务
48篇 您的检索式:作者名="ALBERA C"
    题名 作者 年代 出处 被引量
1Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY):two randomised trials显示文摘Noble PW Albera C Bradford WZ 0,,9779:2
2Effect of interferon gam- ma-lb on survival in patients with idiopathic pulmonary fibrosis ( INSPIRE ) : a multicentre, randomized, placebo-controlled trial 显示文摘King TE Jr Albera C Bradford WZ 2009Lancet2009,374,9685:1
3Pirfenidone in patients with idiopathic pulmonary fibrosis(CAPACITY):two randomised trials显示文摘Noble PW Albera C Bradford WZ 2011Lancet2011,377,9779:1
4Pirfenidone in patients with idiopathic pulmonary fibrosis(CAPACITY):two randomised trials显示文摘NOBLE PW ALBERA C BRADFORD WZ 2011Lancet2011,377,9779:1
5Investigation on variability of candidate genes for meat quality traits in Piemontese cattles 显示文摘Ribeca C Bittante G Albera A 2010Italian Journal of Animal Science2010,8,:1
6Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis 显示文摘du BRM Weycker D Albera C 2011Am J Respir Crit Care Med2011,184,4:1
76-Min-ute Walk Test in Idiopathic Pulmonary Fibrosis:Test Vali-dation and Minimal Clinically Important Difference显示文摘DU BOIS R M WEYCKER D ALBERA C 2011Am JR espir Crit Care Med2011,183,9:1
8Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clini- cally important difference显示文摘Du Bois R M Weycker D Albera C 2011American journal of respiratory and critical care medicine2011,183,9:1
9Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY):two randomised trials显示文摘Noble PW Albera C Bradford WZ 2011Lancet2011,377,:1
10Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY) : two randomised trials显示文摘Noble PW Albera C Bradford WZ 2011Lancet2011,377,9779:1
11Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis 显示文摘du Bois RM Weycker D Albera C 2011Am J Respir Crit Care Med2011,184,:1
12Effect of interferongamma-lb on survival in patients with idiopathic pulmonary fibrosis ( INSPIRE ) : a muhicentre, randomised, placebo-controlled trim 显示文摘King TE Jr Albera C Bradford WZ 2009Lancet2009,374,9685:1
13Comprehensive assess- ment of the long-term safety of pirfenidone in patients with idio- pathic pulmonary fibrosis显示文摘Yaleyre D Albera C Bradford WZ 2014Respirology2014,19,5:1
14Forced vital ca- pacity in patients with idiopathic pulmonary fibrosis:Test properties and minimal clinically inportant difference 显示文摘du Bois RM Weycker D Albera C 2011Am JRespir Crit Carw Med2011,184,12:1
15Ascertainmentof individual risk of mortality for patients with idiopathic pulmonary fibrosis 显示文摘du Bois RM Weycker D Albera C 2011Am J Respir Crit Care Med2011,184,4:1
16Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two ran- domised trials显示文摘NOBLE PW ALBERA C BRADFORD WZ 2011The Lancet2011,377,9779:1
17Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY) : two randomized trials 显示文摘Noble PW Albera C Bradford WZ 2011Lancet2011,377,9779:1
18Effect of interferon gamma- lb on survival in patients with idiopathic pulmonary fibrosis ( INSPIRE ) : a muhicentre, randomised, placebo - controlled trial 显示文摘King TE Albera C Bradford WZ 2009Lancet2009,374,9685:1
19Pirfenidone in patients with idiopathic pulmonary fi brosis(CAPACITY):two randomised trials显示文摘Noble PW Albera C Bradford WZ 0,,:1
20Six-minute- walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference 显示文摘DU BOIS RM WEYCKER D ALBERA C 2011American Journal of Respiratory and Critical Care Medicine2011,183,9:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费